KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

Overview of attention for article published in Kidney International, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 10,130)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 85 news outlets
blogs: 4 blogs
policy: 1 policy source
twitter: 468 X users
patent: 2 patents

facebook: 3 Facebook pages
wikipedia: 4 Wikipedia pages
guideline: 9 clinical guideline sources
bluesky: 1 Bluesky user
podcasts: 1 podcast

Readers on

mendeley: 2355 Mendeley

So far, Altmetric has seen 689 X posts from 468 X users, with an upper bound of 981,872 followers.

4/The right answer is persistent /unchanged anti-PLA2R after one IST course 📌Defining resistance harder -anti-PLA2R –ve patients 📷Persistent NS (>6 months, low albumin) → suggests resistance 📷Low-grade proteinuria + normal albumin → Secondary FSGS …

https://t.co/xHfVbqjmiI

RT @tenridayo123: 本日のチームまとめではANCA関連血管炎 (AAV)の免疫抑制薬選択について議論になりました。腎機能低下が顕著な場合にRTXの寛解導入のエビデンスはやや乏しくIvCyやRTXに最初にIvCyを併用するレジメンも選択肢という話が出ました。 h…

本日のチームまとめではANCA関連血管炎 (AAV)の免疫抑制薬選択について議論になりました。腎機能低下が顕著な場合にRTXの寛解導入のエビデンスはやや乏しくIvCyやRTXに最初にIvCyを併用するレジメンも選択肢という話が出ました。 https://t.co/ffPmewOr3Y

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 685 additional X posts.